What role may symptoms play in the diagnosis of airflow limitation? – a study in an elderly population Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008
Does the cardiologist play a role in the diagnosis of COPD? Preliminary results from the SCOP-cardio study Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010
The better explanation of COPD: the clinical role of FVC grouping Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019
Repeatability study comparing plethysmographic and spirometric lung function parameters in COPD patients, asthmatics, and healthy subjects Source: Eur Respir J 2006; 28: Suppl. 50, 221s Year: 2006
Office spirometry in asthma and COPD: role and feasibility in standard practice. Preliminary data of the “SPACE” Italian study Source: Eur Respir J 2003; 22: Suppl. 45, 439s Year: 2003
The role of lung function testing and eNO in monitoring asthma Source: Annual Congress 2013 –Primary Care Programme "Asthma management in clinical practice" Year: 2013
Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases Year: 2015
The role of lung function measurements in identifying severe asthma in school-age children: results from a case-control study Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008
The prevalence of restrictive lung function in a general population obtained by spirometry and bodyplethysmography-Data from the LEAD study Source: International Congress 2019 – Airway physiology Year: 2019
The relationship between lung function and blood pressure and the mediation role of physical activity and cardiorespiratory fitness in adults: cross-sectional results from the EPIMOV study Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018
FEV1/FVC agreement study between two different seasons Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
Is spirometry in general practice adequately performed or not? Preliminary data of an evaluation study in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 329s Year: 2001
Cross-sectional study to evaluate the role of exacerbations in COPD progression Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
A pilot study to test the feasibility of histological characterisation of asthma–COPD overlap Source: Eur Respir J, 53 (6) 1801941; 10.1183/13993003.01941-2018 Year: 2019
Workstation 4 – Evaluation of spirometric results: review spirometry results by using case studies Source: International Congress 2014 – EW8 Spirometry knowledge and basic skills (European spirometry training programme) Year: 2014
Workstation 4 – Evaluation of spirometric results: review spirometry results by using case studies Source: International Congress 2014 – EW7 Spirometry knowledge and basic skills (European spirometry training programme) Year: 2014
Workstation 4 – Evaluation of spirometric results: review spirometry results by using case studies Source: International Congress 2014 – EW9 Spirometry knowledge and basic skills (European spirometry training programme) Year: 2014
A prospective study of systemic inflammation and FEV1 decline Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
FEV6 : a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004